SSS

Scancell Holdings PLC.

No trades
See on Supercharts
Market capitalization
‪110.20 M‬USD
−0.0168USD
‪−14.99 M‬USD
‪6.62 M‬USD
‪891.32 M‬
Beta (1Y)
−0.31

About Scancell Holdings PLC.

CEO
Linda Gillian Durrant
Headquarters
Oxford
Founded
2008
ISIN
GB00B63D3314
FIGI
BBG004MP9J73
Scancell Holdings Plc engages in the development of novel therapeutic vaccines for the treatment of cancer. Its vaccine platform includes Moditope and ImmunoBody. The company was founded by Lindy Gillian Durrant in 1997 and is headquartered in Oxford, the United Kingdom.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of SCNLF is 0.1270 USD — it has decreased by 3.79% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Scancell Holdings PLC. stocks are traded under the ticker SCNLF.
Scancell Holdings PLC. is going to release the next earnings report on Oct 25, 2024. Keep track of upcoming events with our Earnings Calendar.
SCNLF stock is 3.94% volatile and has beta coefficient of −0.31. Check out the list of the most volatile stocks — is Scancell Holdings PLC. there?
One year price forecast for Scancell Holdings PLC. has a max estimate of 0.3812 USD and a min estimate of 0.2668 USD.
Yes, you can track Scancell Holdings PLC. financials in yearly and quarterly reports right on TradingView.
SCNLF net income for the last quarter is ‪−3.09 M‬ USD, while the quarter before that showed ‪−11.02 M‬ USD of net income which accounts for 71.91% change. Track more Scancell Holdings PLC. financial stats to get the full picture.
Today Scancell Holdings PLC. has the market capitalization of ‪110.02 M‬, it has increased by 2.87% over the last week.
No, SCNLF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, SCNLF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Scancell Holdings PLC. stock right from TradingView charts — choose your broker and connect to your account.
SCNLF reached its all-time high on Feb 15, 2023 with the price of 0.5871 USD, and its all-time low was 0.0015 USD and was reached on Jan 18, 2022.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Scancell Holdings PLC. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Scancell Holdings PLC. stock shows the sell signal. See more of Scancell Holdings PLC. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Scancell Holdings PLC. future price: according to them, SCNLF price has a max estimate of 0.38 USD and a min estimate of 0.27 USD. Read a more detailed Scancell Holdings PLC. forecast: see what analysts think of Scancell Holdings PLC. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Scancell Holdings PLC. EBITDA is ‪−14.47 M‬ USD, and current EBITDA margin is −209.03%. See more stats in Scancell Holdings PLC. financial statements.